The ingredients in some of the foods you buy could soon change if the FDA removes a widely-used label from more than a dozen ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

Senator Patrick Brazeau’s personal crusade against alcohol ran into a wall last month when the health ministry refused to ...

Chief Executive Officer Wayne Paterson outlined the company’s DurAVR transcatheter aortic valve replacement (TAVR) program ...

Even as BAT expands beyond trial criteria, patients see gains in LVEF, symptoms, and more. A survival impact remains unclear.

The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...

A new wireless eye implant restored reading vision in some blind adults, allowing many patients to recognize letters and ...

OpenZeppelin questioned OpenAI’s recent EVMbench results after finding that the AI models were likely exposed to vulnerability reports during pretraining.

Three academic perspectives offer insights on the persistent misconceptions about artificial intelligence in healthcare.

For nearly half a century the Iranian regime has demonstrated a maniacal, religiously driven obsession with destroying the ...

Nativo's founder, Justin "JC" Choi, checks in post-acquisition to share how his tech is helping power Life360's new ...

From fitness equipment to voice AI agents to autonomous debugging, our latest Startup Radar spotlight features Seattle-area founders solving problems… Read More ...